Use of patent information to characterize trends in the therapeutic applications of extracellular vesicles derived from mesenchymal stem cells (MSC-EVs)
- 1 March 2022
- journal article
- research article
- Published by Bentham Science Publishers Ltd. in Recent Patents on Biotechnology
Abstract
Extracellular vesicles derived from mesenchymal stromal cells (MSC-EVs) are gaining interest for medical purposes. The promising therapeutic effects exhibited in both preclinical and clinical studies suggest that they may become an alternative for certain applications to cell-based therapies, which are subjected to stricter regulations. The commercial exploitation of these candidates requires a proper patent strategy from both the industry and public research organizations. Here, we raise a global patent literature analysis to identify key players and therapeutic applications in the field. Our results show an increasing rate of patent publications since 2009, with Asia (specifically China) leading the patenting activity. The therapeutic use of MSC-EVs within patent literature covers a wide range of diseases, in which “Dermal and Wounds”, “Neurology” and “Cardiovascular” are the main therapeutic areas. Moreover, most of these patents include “product-by-process” claims, since the therapeutic effects of MSC-EVs could be influenced by their manufacturing process. Our results follow scientific and clinical literature trends.Keywords
This publication has 29 references indexed in Scilit:
- Exosomes in perspective: a potential surrogate for stem cell therapyOdontology, 2018
- Mesenchymal stem cell-derived extracellular vesicles: novel frontiers in regenerative medicineStem Cell Research & Therapy, 2018
- Shedding light on the cell biology of extracellular vesiclesNature Reviews Molecular Cell Biology, 2018
- Global scientific trends on exosome research during 2007-2016: a bibliometric analysisOncotarget, 2017
- Concise Review: MSC-Derived Exosomes for Cell-Free TherapyStem Cells, 2017
- The limited benefit of “product-by-process” claimHuman Vaccines & Immunotherapeutics, 2016
- Inflammation to Pulmonary DiseasesMediators of Inflammation, 2016
- Towards Therapeutic Delivery of Extracellular Vesicles: Strategies for In Vivo Tracking and Biodistribution AnalysisStem Cells International, 2016
- Exosomes in neurological disease, neuroprotection, repair and therapeutics: problems and perspectivesNeural Regeneration Research, 2015
- Applying extracellular vesicles based therapeutics in clinical trials – an ISEV position paperJournal of Extracellular Vesicles, 2015